Supplementary Material for: Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort
datasetposted on 27.04.2018, 06:47 by Elimova E., Wang X., Qiao W., Sudo K., Wadhwa R., Shiozaki H., Shimodaira Y., Planjery V., Charalampakis N., Lee J.H., Weston B.R., Bhutani M.S., Komaki R., Rice D.C., Swisher S.G., Blum M.A., Rogers J.E., Skinner H.D., Maru D.M., Hofstetter W.L., Ajani J.A.
Objective: The goal of surveillance after therapy of localized esophageal cancer (LEC) is to identify actionable relapses amenable to salvage; however, the current surveillance algorithms are not optimized. We report on a large cohort of LEC patients with actionable locoregional relapses (LRRs). Methods: Between 2000 and 2013, 127 (denominator = 752) patients with actionable LRR were identified. Histologic/cytologic confirmation was the gold standard. All surveillance tools (imaging, endoscopy, fine needle aspiration) were assessed. Results: Most patients were men (89%), had adenocarcinoma (79%), and had no new symptoms (72%) when diagnosed with LRR. In trimodality patients, endoscopic confirmation of positron emission tomography-computed tomography-suspected LRR occurred in only 44%, and 56% required additional tools (e.g., fine needle aspiration). Alternatively, in bimodality patients, endoscopy confirmed LRRs in 81%. Trimodality patients had a higher risk of subsequent LRR/distant metastases after the first LRR than the bimodality patients (p = 0.03). In all patients, 78% of the subsequent relapses were distant. For patients who were salvaged, survival was significantly prolonged (50.6 vs. 25.1 months, p < 0.01). Conclusions: Patients live longer after successful salvage of the LRR than if salvage is not possible. After LRR, patients have a high risk of subsequent distant metastasis and whether the second relapse is local or distant, survival is uniformly poor.